PALI

Palisade Bio, Inc. - Common Stock (PALI)

About Palisade Bio, Inc. - Common Stock (PALI)

Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies for inflammatory bowel diseases. Its programs include PALI-2108 and LB1148. The company was founded on September 6, 2011 and is headquartered in Denver, CO.

Details

Daily high

$2.12

Daily low

$2.05

Price at open

$2.08

52 Week High

$2.86

52 Week Low

$0.53

Market cap

366.3M

Dividend yield

0.00%

Volume

886,468

Avg. volume

2.2M

P/E ratio

-1.98

Palisade Bio, Inc. - Common Stock News